Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

3

Possibly Marketed Outside US

3

Investigational

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

4

1981

1

1998

1

2001

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Structurally Diverse

4

Concept

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

NDF-RT

7

EVMPD

4

FDA UNII

4

DAILYMED

3

DRUG BANK

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

2

ANTIINFECTIVES FOR SYSTEMIC USE

1

VARIOUS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

IMMUNOSUPPRESSANTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

VACCINES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

IMMUNOSUPPRESSANTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

BACTERIAL VACCINES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Selective immunosuppressants

2

Antidotes

1

Tuberculosis vaccines

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

4

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Established Pharmacologic Class [EPC]|Immunoglobulin G [EPC]" in comments (approximate match)

Showing 1 - 7 of 7 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

EQUINE BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN

PGV553HXTK

Status:

Investigational

Class:

STRUCTURALLY DIVERSE

OVINE DIGOXIN IMMUNE FAB

YB12NQZ1YN

Status:

Possibly Marketed Outside US

First approved in 2001

Class:

STRUCTURALLY DIVERSE

LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN

D7RD81HE4W

Status:

Possibly Marketed Outside US

First approved in 1998

Class:

STRUCTURALLY DIVERSE

EQUINE THYMOCYTE IMMUNE GLOBULIN

475247QF1Z

Status:

Possibly Marketed Outside US

First approved in 1981

Class:

STRUCTURALLY DIVERSE

LYMPHOCYTE IMMUNE GLOBULIN, ANTI-THYMOCYTE GLOBULIN (EQUINE)

475247QF1Z

Status:

Other

Class:

CONCEPT

DIGOXIN IMMUNE FAB (OVINE)

YB12NQZ1YN

Status:

Other

Class:

CONCEPT

DIGOXIN IMMUNE FAB, OVINE

YB12NQZ1YN

Status:

Other

Class:

CONCEPT

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1